Loading provider…
Loading provider…
Surgical Oncology Physician in New York, NY
NPI: 1043531163Primary Practice Location
WHITE PLAINS HOSPITAL CENTER
20 Davis Ave, White Plains, NY
Primary Employer
Memorial Sloan Kettering Cancer Center
mskcc.org
HQ Phone
Get M.D. Stephanie's Phone Numberphone_androidMobile
Get M.D. Stephanie's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2017 - 2027
NC State Medical License
2018 - 2022
PA State Medical License
2010 - 2017

American Board of Surgery
Surgery
Memorial Sloan Kettering Cancer Center
Fellowship • Breast Surgical Oncology
2017 - 2018
UPMC Medical Education (Pittsburgh)
Residency • Surgery
2010 - 2017
University of Pittsburgh School of Medicine
Medical School
Until 2010
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99205New patient office or other outpatient visit, typically 60 minutes | 25 | 25 |
| 2 | 19301Partial removal of breast | 18 | 19 |
| 3 | 99212Established patient outpatient visit, total time 10-19 minutes | 16 | 23 |
Surgical Axillary Staging Before Neoadjuvant Chemotherapy: Who Gets It and Why We Should Avoid It
Authors: Kathleen Iles, Paula D Strassle, Chris B. Agala, Julia Button, Stephanie Downs-Canner
Publication Date: 2021-08
Authors: Nour Abuhadra, George Plitas, Monica Morrow
Journal: Ann Surg Oncol
Publication Date: 2025-03-02
ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
Authors: Nour Abuhadra, George Plitas, Giacomo Montagna, Monica Morrow
Publication Date: 2024-08
Lead Sponsor: Julie Nangia
Collaborators: Incyte Corporation, Translational Breast Cancer Research Consortium
Intervention / Treatment: DRUG: Ruxolitinib, DRUG: Placebo (for Ruxolitinib)